137 related articles for article (PubMed ID: 8573687)
1. Pharmacokinetics of terbinafine and of its five main metabolites in plasma and urine, following a single oral dose in healthy subjects.
Humbert H; Cabiac MD; Denouël J; Kirkesseli S
Biopharm Drug Dispos; 1995 Nov; 16(8):685-94. PubMed ID: 8573687
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of terbinafine and five known metabolites in children, after oral administration.
Humbert H; Denouël J; Cabiac MD; Lakhdar H; Sioufi A
Biopharm Drug Dispos; 1998 Oct; 19(7):417-23. PubMed ID: 9818707
[TBL] [Abstract][Full Text] [Related]
3. Dose-proportional pharmacokinetics of terbinafine and its N-demethylated metabolite in healthy volunteers.
Kovarik JM; Kirkesseli S; Humbert H; Grass P; Kutz K
Br J Dermatol; 1992 Feb; 126 Suppl 39():8-13. PubMed ID: 1543677
[TBL] [Abstract][Full Text] [Related]
4. Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites.
Kovarik JM; Mueller EA; Zehender H; Denouël J; Caplain H; Millerioux L
Antimicrob Agents Chemother; 1995 Dec; 39(12):2738-41. PubMed ID: 8593011
[TBL] [Abstract][Full Text] [Related]
5. Analytical methods for the determination of terbinafine and its metabolites in human plasma, milk and urine.
Schatz F; Haberl H
Arzneimittelforschung; 1989 Apr; 39(4):527-32. PubMed ID: 2751743
[TBL] [Abstract][Full Text] [Related]
6. Terbinafine pharmacokinetics after single dose oral administration in the dog.
Sakai MR; May ER; Imerman PM; Felz C; Day TA; Carlson SA; Noxon JO
Vet Dermatol; 2011 Dec; 22(6):528-34. PubMed ID: 21599768
[TBL] [Abstract][Full Text] [Related]
7. Single dose pharmacokinetics of terbinafine in cats.
Wang A; Ding H; Liu Y; Gao Y; Zeng Z
J Feline Med Surg; 2012 Aug; 14(8):540-4. PubMed ID: 22403416
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of terbinafine after oral administration of a single dose to Hispaniolan Amazon parrots (Amazona ventralis).
Evans EE; Emery LC; Cox SK; Souza MJ
Am J Vet Res; 2013 Jun; 74(6):835-8. PubMed ID: 23718650
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjects.
Jiang X; Wang N; Zhang ZJ; Tian Y; Chen Y
Arzneimittelforschung; 2008; 58(7):363-6. PubMed ID: 18751504
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of terbinafine after single oral dose administration in red-tailed hawks (Buteo jamaicensis).
Bechert U; Christensen JM; Poppenga R; Fahmy SA; Redig P
J Avian Med Surg; 2010 Jun; 24(2):122-30. PubMed ID: 20806657
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and metabolism of genaconazole, a potent antifungal drug, in men.
Lin C; Kim H; Radwanski E; Affrime M; Brannan M; Cayen MN
Antimicrob Agents Chemother; 1996 Jan; 40(1):92-6. PubMed ID: 8787886
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of oral terbinafine in horses and Greyhound dogs.
Williams MM; Davis EG; KuKanich B
J Vet Pharmacol Ther; 2011 Jun; 34(3):232-7. PubMed ID: 21492187
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of terbinafine in young children treated for tinea capitis.
Abdel-Rahman SM; Herron J; Fallon-Friedlander S; Hauffe S; Horowitz A; Rivière GJ
Pediatr Infect Dis J; 2005 Oct; 24(10):886-91. PubMed ID: 16220086
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of nebulized terbinafine in Hispaniolan Amazon parrots (Amazona ventralis).
Emery LC; Cox SK; Souza MJ
J Avian Med Surg; 2012 Sep; 26(3):161-6. PubMed ID: 23156978
[TBL] [Abstract][Full Text] [Related]
15. An investigation of the pharmacokinetics of topical terbinafine (Lamisil) 1% cream.
Hill S; Thomas R; Smith SG; Finlay AY
Br J Dermatol; 1992 Oct; 127(4):396-400. PubMed ID: 1419761
[TBL] [Abstract][Full Text] [Related]
16. Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses.
Kienzler JL; Queille-Roussel C; Mugglestone C; Ortonne JP; Larnier C
Curr Med Res Opin; 2007 Jun; 23(6):1293-302. PubMed ID: 17559730
[TBL] [Abstract][Full Text] [Related]
17. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
18. Aqueous humor and plasma concentrations of a compounded 0.2% solution of terbinafine following topical ocular administration to normal equine eyes.
Clode A; Davis J; Davidson G; Salmon J; Lafevers H; Gilger B
Vet Ophthalmol; 2011 Jan; 14(1):41-7. PubMed ID: 21199278
[TBL] [Abstract][Full Text] [Related]
19. Determination of terbinafine and its desmethyl metabolite in human plasma by high-performance liquid chromatography.
Denouël J; Keller HP; Schaub P; Delaborde C; Humbert H
J Chromatogr B Biomed Appl; 1995 Jan; 663(2):353-9. PubMed ID: 7735483
[TBL] [Abstract][Full Text] [Related]
20. Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks.
Faergemann J; Zehender H; Denouël J; Millerioux L
Acta Derm Venereol; 1993 Aug; 73(4):305-9. PubMed ID: 7904107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
